South Korean AI developer Vuno plans to highlight AI-supported brain MRI software at the Alzheimer's Association International Conference (AAIC) to be held in July in Philadelphia.
In a series of poster presentations, the company will feature results from studies that used its Vuno Med-DeepBrain white matter hyperintensities measurement tool. The U.S. Food and Drug Administration (FDA) cleared the software in October 2023.
Posters will include the following:
- "Quantitative Analysis of Choroid Plexus Enlargement in Alzheimer's Dementia: A Study of Automated Volumetric Technique"
- "Automated Brain Volumetry Analysis for Differential Diagnosis of Frontotemporal Dementia Subtypes"
- "Comparison of Intracranial Volume Adjustment Methods to Evaluate Brain Atrophy Severity in AD Continuum"
Vuno researchers and a radiologist will present research findings and address audience questions at the conference, the company said.
